F. Costa

发表

Low-energy amplitude-modulated radiofrequency electromagnetic fields as a systemic treatment for cancer: Review and proposed mechanisms of action

J. Tuszynski, F. Costa, 2022, Frontiers in Medical Technology.

Low energy amplitude modulated radiofrequency electromagnetic fields in combination with standard treatment or as monotherapy to show improvement in quality of life in patients with advanced hepatocellular carcinoma.

J. Tuszynski, N. Horvat, B. Gumz, 2021 .

Low energy amplitude modulated radiofrequency electromagnetic fields to show antitumor effect in combination with standard treatment or as monotherapy in patients with advanced hepatocellular carcinoma.

J. Tuszynski, N. Horvat, B. Gumz, 2021 .

Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies

A. Barbault, B. Pasche, I. Brezovich, 2013, Chinese journal of cancer.

Cancer cell proliferation is inhibited by specific modulation frequencies

D. Absher, R. Myers, N. Kuster, 2011, British Journal of Cancer.

Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields

N. Kuster, A. Barbault, B. Pasche, 2011, British Journal of Cancer.

A phase II study of amplitude-modulated electromagnetic fields in the treatment of advanced hepatocellular carcinoma (HCC)

M. C. Chammas, A. Barbault, B. Pasche, 2007 .

Low‐energy amplitude‐modulated electromagnetic field exposure: Feasibility study in patients with hepatocellular carcinoma

J. Tuszynski, G. Abou-Alfa, N. Horvat, 2023, Cancer medicine.

Selecting patients for cytotoxic therapies in gastroenteropancreatic neuroendocrine tumours.

B. Pasche, F. Costa, B. Gumz, 2012, Best practice & research. Clinical gastroenterology.